Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1565 |
Deferiprone
去铁酮,Deferidone,CP20 |
Others; HCV Protease; Ferroptosis; UGT | Apoptosis; Metabolism; Microbiology/Virology; Others; Proteases/Proteasome |
Deferiprone (Deferidone) 是口服活性铁螯合剂,可研究地中海贫血中的输血性铁过载。 | |||
T27066 |
Prostaglandin G/H synthase 1 inhibitor
CP74006,CP 74006,2-Amino-N-(4-chlorophenyl)benzamide |
Others | Others |
Prostaglandin G/H synthase 1 inhibitor (CP 74006) 是一种选择性D5D 抑制剂,IC(50)值为20nM。 | |||
T2398 |
Tofacitinib Citrate
CP-690550 citrate,柠檬酸托法替尼,枸橼酸托法替尼,Tasocitinib citrate,Tofacitinib (CP-690550) Citrate |
Apoptosis; Influenza Virus; JAK; Antibacterial; Antifungal | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Microbiology/Virology; Stem Cells |
Tofacitinib Citrate (CP-690550 citrate) 是 JAK1/2/3抑制剂,IC50分别为112,20 和 1 nM。它具有抗菌,抗真菌和抗病毒活性。 | |||
T10873 | CP-96486 | Others | Others |
CP-96486 is a potent and orally active antagonist of leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor (Kis: 20 and 24 nM). | |||
T35915 |
Erlotinib-13C6
Erlotinib-13C6 |
||
Erlotinib-13C6 (CP-358774-13C6) is a 13C-labeled Erlotinib. Erlotinib is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR[1]. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer[1].Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process[2]... |